Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways
Conclusions: The results of our study suggest that low-dose IL-2 has therapeutic effects on DSS-induced colitis and potential clinical value in treating UC.
Source: Theranostics - Category: Molecular Biology Authors: Hana Lee, Ye Seul Son, Mi-Ok Lee, Jea-Woon Ryu, Kunhyang Park, Ohman Kwon, Kwang Bo Jung, Kwangho Kim, Tae Young Ryu, Aruem Baek, Janghwan Kim, Cho-Rok Jung, Choong-Min Ryu, Young-Jun Park, Tae-Su Han, Dae-Soo Kim, Hyun-Soo Cho, Mi-Young Son Tags: Research Paper Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Genetics | Hepatitis | Hepatitis C | Inflammatory Bowel Disease | Molecular Biology | Sodium | Study | Ulcerative Colitis | Vasculitis